MicrosoftTeams-image (5).png
Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study
13 avr. 2023 17h30 HE | Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by...
Global Cardiac Resynchronization Therapy (CRT) Devices Market
Outlook on the Cardiac Resynchronization Therapy Devices Global Market to 2027 - Rising Prevalence of Cardiovascular Diseases is a Main Driving Factor
19 sept. 2022 06h48 HE | Research and Markets
Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Cardiac Resynchronization Therapy (CRT) Devices Market - Analysis By Product (CRT-D, CRT-P), End-User By Region, By Country (2022 Edition):...
22157.jpg
Global Cardiac Monitoring & Cardiac Rhythm Management Devices Markets, Competition, Forecast & Opportunities, 2017-2021 & 2022-2027
04 août 2022 08h33 HE | Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders,...
Global Cardiovascular Implants Market
Insights on the Cardiovascular Implants Global Market to 2027 - by Product Type, Material, Procedure Type, Indication and Region
27 juin 2022 08h13 HE | Research and Markets
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "Cardiovascular Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Pacemaker Market
Global Pacemaker Market Report to 2027 - by Type, Technology, Product Type, Applications, End-user and Region
24 juin 2022 06h08 HE | Research and Markets
Dublin, June 24, 2022 (GLOBE NEWSWIRE) -- The "Global Pacemaker Market, By Type (Implantable v/s External), By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type, By...
Global Implantable Cardiac Rhythm Management Device Market
Insights on the Implantable Cardiac Rhythm Management Device Global Market to 2030 - Increasing Incidence of Cardiac Disorders is Driving Growth
03 juin 2022 07h48 HE | Research and Markets
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report by Product (Pacemaker, ICDs, CRT), by End Use (Hospitals,...
Global Cardiac Bio Implant Devices Market
Global Cardiac Bio Implant Devices Market Report 2022 Featuring Agilent, Eurofins Scientific, F. Hoffman-La Roche, Illumina,, Natera, PerkinElmer, Quest Diagnostics, Thermo Fisher Scientific
04 mai 2022 04h33 HE | Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Global Cardiac Bio Implant Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis" report has...
researchdrivelogo.jpg
Global Pacemaker Market Expected to Rise at a CAGR of 5.5% and Surpass $6,447.5 Million during the Forecast Period from 2021 to 2028 [175-Pages] | Confirmed by Research Dive
14 mars 2022 09h10 HE | Research Dive
New York, USA, March 14, 2022 (GLOBE NEWSWIRE) -- According to Research Dive, the global pacemaker market is estimated to generate a revenue of $6,447.5 million by 2028 and grow at a CAGR of...
Global Cardiac Rhythm Management Devices Market
Global $31.9 Billion Cardiac Rhythm Management Devices Markets to 2030
10 févr. 2022 04h08 HE | Research and Markets
Dublin, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The "Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers, Defibrillators, Cardiac Resynchronization...
researchdrivelogo.jpg
Global Pacemaker Market Expected to Rise at a CAGR of 5.5% and Surpass $6,447.5 Million during the Forecast Period from 2021 to 2028 [-Pages] - Divulge by Research Dive
15 déc. 2021 09h00 HE | Research Dive
New York, USA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- According to Research Dive, the global pacemaker market is estimated to generate a revenue of $6,447.5 million by 2028, and grow at CAGR of 5.5% over...